HY-W004520-500mg
|
MedChemexpress LLC
|
Phenazine (methylsulfate) [CAS 299-11-6]
|
|
COVID-19-immunoregulation
|
|
HY-141572-10mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycerol [CAS 24529-88-2]
|
|
|
|
HY-130240-10mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
HY-130240-100mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
HY-130240-5mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
HY-130240-50mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
HY-130240-1mL
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-103254-10mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-100mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-25mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-5mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-50mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
HY-103254-1mL
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|